NEW YORK (GenomeWeb) – CollabRx and Medytox Solutions today said that they have entered into a non-binding letter of intent to negotiate a merger between the firms.

In addition, Medytox is providing CollabRx with a loan so the San Francisco-based bioinformatics firm can continue to operate while the firms negotiate a potential deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.